Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome
about
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosisSerum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.Antibodies against cyclic citrullinated peptides in infectious diseases--a systematic review.Anti-cyclic citrullinated Peptide frequency in patients with chronic hepatitis C virus infection and effect of presence of systemic disease.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionAssociation of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.Gastrointestinal and hepatic manifestations of rheumatoid arthritis.An update on the management of hepatitis C virus-related arthritis.Extrahepatic manifestations in chronic hepatitis C virus carriers.Hepatitis C virus and autoimmunity.Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection.Evaluation of rheumatoid factor and anti-citrullinated peptide antibodies in relation to rheumatological manifestations in patients with leprosy from Southern Brazil.Hepatitis C virus infection and its rheumatologic implications.Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infectionAntibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy.Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.
P2860
Q26773278-942C07F9-84CE-4600-8BF7-F4D202BC1506Q33839099-CABB60BD-5159-4934-9EF8-AC2A6A8CFF5DQ34129802-CB5D1E91-801F-4C0E-AC8C-AA921A2EED39Q34666668-C6A925E5-DE9E-46BD-9B25-F5E4E40BBE08Q35731058-49A59BC8-5DD3-47E8-9AB7-69F93CCEB39EQ37217463-302FE54A-3F69-4323-81BE-D294BFD3537EQ37277626-904EC163-C1EE-4B66-AEBF-ECCB6B907B9AQ37280952-2520E30A-30F4-4970-8037-3A54292A9EBCQ37624583-4318DD3B-701E-4F60-B60B-D2E6365E3095Q37825811-D786D584-7F51-4834-96C9-DB2B04CC74FEQ38242116-B0F6F604-AA0A-40D9-880D-93BE280EEFB0Q38388423-82571453-88E4-416A-ADB7-2D73A7A6567AQ38497354-56CD60B1-58B1-4E96-A22D-05EE096BB67CQ38896045-E5C80DA6-08BD-4769-890B-41301E0DA1FCQ40511427-F71BA263-8E5F-4844-9381-F9242D6B1634Q41560603-E9C7B876-3599-4467-9773-10E7165104F2Q41806895-A953EFD5-F2DB-4849-977C-E49DA28DD7A8Q43042184-E8EF7723-3430-42A3-B21C-1FDFC97D7020Q46351758-CD45D300-855E-4F61-9E9D-3786F7833383Q49160612-603F7BAF-5335-48AE-9093-7D2C9E89E9A0Q55027429-3E353845-DCE6-43C9-9ECB-17B19F10B3C7
P2860
Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@ast
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@en
type
label
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@ast
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@en
prefLabel
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@ast
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@en
P2093
P2860
P356
P1476
Anti-cyclic citrullinated pept ...... tations and Sjogren's syndrome
@en
P2093
P Ghillani-Dalbin
T van Boekel
V Thibault
P2860
P304
P356
10.1136/ARD.2005.038042
P407
P577
2006-03-01T00:00:00Z